Intracranial hemorrhage in immune thrombocytopenia (ITP): fatal course in spite of maximum therapy

B Uetz; A Wawer; M Nathrath; S Burdach

doi:10.1055/s-0030-1263182

Intracranial hemorrhage in immune thrombocytopenia (ITP): fatal course in spite of maximum therapy

Klin Padiatr. 2010 Nov;222(6):383-5. doi: 10.1055/s-0030-1263182. Epub 2010 Sep 9.

Authors

B Uetz¹, A Wawer, M Nathrath, S Burdach

Affiliation

¹ Technische Universität München, Department of Pediatrics and Pediatric Oncology Center, Kölner Platz 1, Munich, Germany. Barbara.Uetz@lrz.tu-muenchen.de

PMID: 20830661
DOI: 10.1055/s-0030-1263182

Abstract

We report the case of a 2-year-old boy with immune thrombocytopenia (ITP) who developed fatal intracranial hemorrhage (ICH) despite maximum therapy according to the guidelines. Hitherto defined risk factors do not predict severe or atypical courses.

Publication types

Case Reports

MeSH terms

Anti-Inflammatory Agents / therapeutic use*
Child, Preschool
Combined Modality Therapy
Craniotomy*
Disease Progression
Erythrocyte Transfusion*
Fatal Outcome
Hemorrhage / therapy
Humans
Immunoglobulin G / therapeutic use*
Intracranial Hemorrhages / therapy*
Male
Platelet Count
Platelet Transfusion*
Prednisolone / therapeutic use*
Purpura, Thrombocytopenic, Idiopathic / therapy*
Risk Factors

Substances

Anti-Inflammatory Agents
Immunoglobulin G
Prednisolone